Abatacept
Cohort Studies
Cyclosporine/*therapeutic use
Female
Follow-Up Studies
Glomerular Filtration Rate
Graft Rejection/*prevention & control
Humans
Immunoconjugates/*therapeutic use
Immunosuppressive Agents/*therapeutic use
International Agencies
Kidney Failure, Chronic/*surgery
Kidney Function Tests
*Kidney Transplantation
Lipids/blood
Lymphoproliferative Disorders/prevention & control
Male
Maximum Tolerated Dose
Middle Aged
Postoperative Complications/prevention & control
Prognosis
Safety
Time Factors
*Tissue Donors
